-

Cushman & Wakefield Brokers $300M Sale of Office Building in Jersey City

JERSEY CITY, N.J.--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK) announced that the real estate services firm has arranged the sale of a 431,281-square-foot office building located at 70 Hudson Street in Jersey City, New Jersey. The final sale price was $300 million.

Cushman & Wakefield’s David Bernhaut, Adam Spies, Kevin Donner, Marcella Fasulo, Andrew Merin, Gary Gabriel, Frank DiTommaso and Ryan Larkin, along with local leasing specialists Ed Duenas and Rob Lowe, represented the seller, a joint venture between Danish institutional investor PFA Pension and Spear Street Capital. The asset was acquired by Vision Properties and Hana Alternative Asset Management, who was advised by Alpha Asset Management.

“Since 2016, the sellers have invested tens of millions of dollars to reposition this asset, resulting in 70 Hudson being one of the highest quality buildings on the waterfront,” said Bernhaut.

“We received significant interest in this property given the credit tenancy, occupancy and location in a key office market in New Jersey,” added Spies.

Anthony Arena, President of Vision Properties added, “Due to the several qualities highlighted by the Cushman team, 70 Hudson is a premium office destination for credit tenants in the market. We are excited to grow our footprint along the New Jersey waterfront with such a tremendous asset and continue to drive value for our investors.”

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global real estate services firm that delivers exceptional value for real estate occupiers and owners. Cushman & Wakefield is among the largest real estate services firms with approximately 50,000 employees in over 400 offices and approximately 60 countries. In 2021, the firm had revenue of $9.4 billion across core services of property, facilities and project management, leasing, capital markets, and valuation and other services. To learn more, visit www.cushmanwakefield.com or follow @CushWake on Twitter.

Contacts

Jayden Lapin-Tatman
Communications Manager, East Region
212-841-5052
Jayden.LapinTatman@cushwake.com

Cushman & Wakefield

NYSE:CWK

Release Summary
Cushman & Wakefield has arranged the $300 million sale of a 431,281-square-foot office building in Jersey City, New Jersey.
Release Versions
Hashtags

Contacts

Jayden Lapin-Tatman
Communications Manager, East Region
212-841-5052
Jayden.LapinTatman@cushwake.com

More News From Cushman & Wakefield

Cushman & Wakefield: U.S. Legal Sector Leasing Hits Record 7.3 Million Square Feet in Q2 2026 as Law Firms Expand Footprints

NEW YORK--(BUSINESS WIRE)--U.S. legal sector leasing reached a quarterly record of 7.3 million square feet (sf) in the second quarter of 2026, surpassing the previous quarterly high by 23%, according to a new report from Cushman & Wakefield. First-half legal leasing reached nearly 12.2 million sf, up 17% year over year, as law firm demand continued to contribute to the recovery in U.S. office leasing. “The legal sector is showing a clear preference for larger footprints, with expansion acti...

Cushman & Wakefield Releases 2026 Data Center Development Cost Guide, Citing 21% Rise in Per-MW Construction Costs

NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK), a leading global commercial real estate services firm, has published its 2026 Data Center Development Cost Guide, revealing that data center construction costs have risen an average of 21% per megawatt (MW) since the previous edition was published in the fourth quarter of 2024. Covering markets across the United States and Canada, the guide provides a comprehensive overview of data center development economics spanning land acquisi...

Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows

NEW YORK--(BUSINESS WIRE)--The U.S. life sciences real estate sector is moving toward a gradual rebalancing as development activity contracts, investment sales recover and funding conditions strengthen, according to the latest Life Sciences Update from Cushman & Wakefield. While elevated vacancy and softer rents continue to weigh on near-term fundamentals, a reduced construction pipeline and improving demand indicators are positioning the market for healthier long-term growth. U.S. life sci...
Back to Newsroom